摘要
目的:探讨卡维地罗治疗老年性高血压的安全性和有效性。方法:随机选择89例老年原发性高血压患者,服用卡维地罗(12.5 -50mg/d),测定临床血压值。结果:服药8周后有效率达83.7%(72/86),收缩压治疗前164.3±21.1mmHg降到治疗后142.4± 16.4mm Hg,舒张压治疗前105.8±12.5 mmHg降到治疗后91.2±8.7 mmHg;心率由治疗前的71.5±6.1次/min到治疗后63.7± 5.6次/min。有3例患者因心动过缓和心悸不适不能耐受而停药,无严重不良反应。结论:卡维地罗治疗老年原发性高血压有较好的疗效和安全性、临床耐受性好。
Objective: To investigate the antihypertensive effect, safety and tolerability of carvedilol on older patients with hypertension, Methods:This is a randomized, open and dose-titration study. With Carvedilol an option to increase the dose from 12.5 nag to 50mg daily after 8 weeks and followed by an open 3-month active treatment period. Blood pressure in observation was made during the period and at the end of the active treatment period. Results: After 12 weeks of administration, blood pressure and the heart rate (HR) declined significantly. Systolic blood pressure declined from 164.3 ± 21.1 mmHg to 142.4 ± 16.4 mm Hg,diastolic blood pressure declined from 105.8 ± 12. 5 to 91.2 ± 8.7 mm Hg (P〈0. 001) ; Heart rate declined from 71.5 ± 6. 1 bpm to 63.7 ± 5.6 bpm(P〈0. 001 ), No symptoms of adverse reaction were detected. Condusion:Carvedilol is an effective antihypertensive agent that can be used in people with essential hypertension in all age groups, Especially in the older.
出处
《中国临床医学》
北大核心
2005年第6期1142-1143,共2页
Chinese Journal of Clinical Medicine
关键词
卡维地罗
老年
高血压
Carvedilol
Essential Hypertension
Elderly